lum-201
Generic: ibutamoren·Code: LUM-201, MK-0677
lum-201: developed by 1 company · 1 clinical trial tracked. Updated within the last hour.
Development Pipeline (1)
| Company | Phase |
|---|---|
| LUMOS PHARMA, INC. (NLNK) | Phase 3 |
Clinical Trials (1)
A Long-term Extension Study to Evaluate the Safety and Tolerability of Daily Oral LUM-201 in Children With Growth Hormone Deficiency (GHD)
Frequently asked questions
Who is developing lum-201?
lum-201 is being developed by LUMOS PHARMA, INC..
How many clinical trials involve lum-201?
BioSniper tracks 1 clinical trial involving lum-201.
Get deeper analysis on lum-201
Full trial data, mechanism of action, competitive landscape, and AI-powered insights.
Start Free Analysis